This inventor holds 3 USPTO granted patents. Top assignees: Cytran, Inc., Melmotte, Inc.. Active years: 1999-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999-2005
Title: Innovator Spotlight: John W. Blasecki
Introduction
John W. Blasecki, an esteemed inventor hailing from Woodinville, Washington, has made significant contributions in the field of pharmaceuticals. With a focus on angiostatic therapies, he holds three patents that reflect his innovative approach to solving complex medical challenges.
Latest Patents
Blasecki's latest patents include groundbreaking work on pharmaceutical angiostatic dipeptide compositions. One notable patent discloses methods of inhibiting neovascularization in a subject by administering a pharmaceutical preparation of R'-Glu-Trp-R''. Another of his key patents outlines similar methods utilizing R'-Glu-Trp-R'', further emphasizing his commitment to advancing medical research and treatments.
Career Highlights
Throughout his career, John W. Blasecki has worked with prominent companies such as Cytran, Inc. and Melmotte, Inc. His innovative mindset and dedication to research have positioned him as a valuable contributor in the pharmaceutical industry. His patents not only broaden the scope of treatment options but also offer potential solutions to pressing health issues.
Collaborations
Blasecki has collaborated with various professionals in the industry, including notable coworker Lawrence R. Green. These partnerships have facilitated a productive exchange of ideas and fostered an environment conducive to innovation.
Conclusion
In summary, John W. Blasecki is an inspiring figure in the realm of pharmaceutical innovations. His patents showcase a commitment to addressing critical health challenges through advanced therapeutic solutions. As he continues to push the boundaries of research, his contributions will undoubtedly leave a lasting impact on the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile